IndiaOne Finance - Company Dashboard

Governance Classic Home

RPG Life Sciences LtdPharmaceuticalsINE105J01010Consolidated₹2802.40-22.10 (-0.78%)Jun-26

Valuation

Market Cap₹4.63K Cr

TTM PE155.00x

Forward PE41.99x

PEG-3.64

Book Value₹366.03

P/B7.66x

TTM EPS₹18.08

Fwd EPS₹66.75

TTM Revenue₹707.52 Cr

TTM PAT₹115.17 Cr

TTM EBITDA₹147.09 Cr

TTM EBIT₹125.61 Cr

Last Qtr PAT₹30.76 Cr

Last Qtr EBITDA₹147.09 Cr

Last Qtr EBIT₹125.61 Cr

Profitability

ROE19.02%

ROCE149.50%

TTM NPM16.28%

TTM EBITDA %20.79%

Curr OPM15.35%

Last OPM15.80%

Curr NPM—

Last NPM—

Curr EPS₹18.60

Last EPS₹18.08

Balance sheet

Equity₹13.23 Cr

Reserve₹592.15 Cr

Total Debt₹20.00 Cr

D/E0.03x

Interest %2.05%

Curr Interest₹0.63 Cr

Price / range

Close₹2802.40

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.78%

1W+3.85%

1M+3.69%

3M+23.01%

6M+46.58%

1Y+16.85%

2Y+28.88%

3Y+121.57%

5Y+331.11%

Diwali+21.66%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	195.69+15.8%	176.89	180.03	181.68	168.92	707.52
Other Income	4.16	12.36	3.41	4.54	5.23	25.54
Total Income	199.85+14.8%	189.25	183.44	186.22	174.15	733.06
Interest	0.63	0.39	0.25	0.12	0.13	0.89
Expenditure	-158.64-14.4%	-150.15	-145.90	-147.99	-138.72	-582.76
PBDT	0	0	0	0	0	0
EBITDA	43.58+22.9%	32.87	39.76	39.03	35.47	147.13
Depreciation	-5.90	-5.74	-5.38	-5.22	-5.14	-21.48
EBIT	37.68+24.2%	27.13	34.38	33.81	30.33	125.65
PBT	41.21+16.3%	40.20	29.12	49.45	35.43	154.20
Tax	-10.64	-10.30	-6.99	-12.60	-9.14	-39.03
Equity	13.23	13.23	0	0	13.23	13.23
OPM	20.62	21.24	16.18	27.22	20.34	21.04
Net Profit	30.57+16.3%	29.90	22.13	36.85	26.29	115.17
NPM	15.30	15.80	12.29	20.28	15.10	15.71
EPS	18.49+16.3%	18.08	13.38	22.28	15.90	69.64

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	707.52+8.3%	653.43+12.3%	582.05+13.5%	512.81+16.5%	440.16+13.1%	389.14
Other Income	25.54	12.68	7.21	4.80	2.99	0.91
Total Income	733.06+10.1%	666.11+13.0%	589.26+13.8%	517.61+16.8%	443.15+13.6%	390.05
Expenditure	-582.76-13.0%	-515.83-9.4%	-471.42-10.7%	-425.93-15.1%	-369.98-10.0%	-336.47
Interest	-0.89	-0.62	-0.45	-0.31	-0.52	-0.79
PBDT	0	0	0	0	0	0
EBITDA	147.13-7.8%	159.65+24.6%	128.15+24.8%	102.69+18.9%	86.36+23.5%	69.93
Depreciation	-21.48	-21.43	-17.07	-15.50	-15.66	-16.47
EBIT	125.65-9.1%	138.22+24.4%	111.08+27.4%	87.19+23.3%	70.70+32.2%	53.46
PBT	154.20-33.8%	232.88+97.6%	117.84+28.5%	91.68+25.3%	73.17+36.6%	53.58
Tax	-39.03	-49.64	-30.18	-24.04	-21.69	-13.58
Equity	13.23	13.23	0	0	0	0
OPM (%)	21.04	34.96	20.00	18.00	17.00	14.00
Net Profit	115.17-37.1%	183.24+109.0%	87.66+29.6%	67.64+31.4%	51.48+28.7%	40
NPM (%)	15.71	27.51	15.00	13.00	12.00	10.00
EPS (Rs)	69.64-37.1%	110.80+109.0%	53.01+29.6%	40.90+31.4%	31.13+28.7%	24.19
CEPS	69.64	110.80	53.01	40.90	31.13	24.19

Metric	Jun-26	Mar-26	Dec-25	FY25-26
Revenue	195.69	176.89	180.03	707.52
Other Income	4.70	12.40	3.41	25.58
Total Income	200.39	189.29	183.44	733.10
Interest	0.63	0.39	0.25	0.89
Expenditure	-158.93	-150.19	-145.90	-582.80
PBDT	0	0	0	0
EBITDA	43.29	32.83	39.76	147.09
Depreciation	-5.90	-5.74	-5.38	-21.48
EBIT	37.39	27.09	34.38	125.61
PBT	41.46	40.20	29.12	154.20
Tax	-10.70	-10.30	-6.99	-39.03
Equity	13.23	13.23	0	13.23
OPM	20.69	21.24	15.87	21.03
Net Profit	30.76	29.90	22.13	115.17
NPM	15.35	15.80	12.06	15.71
EPS	18.60	18.08	13.38	18.08

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	707.52+8.3%	653.43
Other Income	25.58	12.68
Total Income	733.10+10.1%	666.11
Expenditure	-582.80-13.0%	-515.83
Interest	-0.89	-0.62
PBDT	0	0
EBITDA	147.09-7.9%	159.65
Depreciation	-21.48	-21.43
EBIT	125.61-9.1%	138.22
PBT	154.20-33.8%	232.88
Tax	-39.03	-49.64
Equity	13.23	13.23
OPM (%)	21.03	34.96
Net Profit	115.17-37.1%	183.24
NPM (%)	15.71	27.51
EPS (Rs)	18.08-83.7%	110.80
CEPS	69.64	110.80

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	24	09 Jul 2026
2025	Final Dividend	20	27 Jun 2025
2025	Special Dividend	4	27 Jun 2025
2024	Final Dividend	16	28 Jun 2024
2023	Final Dividend	12	21 Jul 2023
2022	Final Dividend	9.6	14 Jul 2022
2021	Final Dividend	7.2	13 Aug 2021
2020	Interim Dividend	4	24 Mar 2020
2019	Final Dividend	2.4	22 Jul 2019
2018	Final Dividend	2.4	19 Jul 2018
2017	Final Dividend	2.8	13 Jul 2017
2016	Interim Dividend	1.6	22 Mar 2016
2015	Final Dividend	0.8	20 Jul 2015
2014	Final Dividend	1.2	11 Sep 2014
2014	Final Dividend	1.2	11 Sep 2014
2014	Special Dividend	0.8	11 Sep 2014
2014	Special Dividend	0.8	11 Sep 2014
2013	Final Dividend	1.2	11 Jul 2013
2012	Final Dividend	0.8	24 Jul 2012
2011	Final Dividend	1.6	14 Jul 2011
2010	Final Dividend	1.44	15 Jul 2010
2009	Final Dividend	1.2	30 Jul 2009
2008	Final Dividend	1.2	11 Aug 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split